NF-κB signaling in the central neuron system plays a vital role by regulating certain functions, such as neuronal plasticity and neuronal growth [32], and the inhibition of NF-κB is a novel target in Alzheimer's disease therapy [33]. The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.